Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 24122286)

1.

Circulating biomarkers in patients with heart failure and preserved ejection fraction.

O'Meara E, de Denus S, Rouleau JL, Desai A.

Curr Heart Fail Rep. 2013 Dec;10(4):350-8. doi: 10.1007/s11897-013-0160-x. Review.

PMID:
24122286
2.

[Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].

Ruiz Ortega RA, Manzano L, Montero-Pérez-Barquero M.

Med Clin (Barc). 2014 Mar;142 Suppl 1:20-5. doi: 10.1016/S0025-7753(14)70078-8. Review. Spanish.

PMID:
24930079
3.

Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.

Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS.

Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5.

PMID:
22869458
4.

Emerging biomarkers in heart failure.

van Kimmenade RR, Januzzi JL Jr.

Clin Chem. 2012 Jan;58(1):127-38. doi: 10.1373/clinchem.2011.165720. Epub 2011 Nov 15. Review.

5.

Biomarkers of heart failure with normal ejection fraction: a systematic review.

Cheng JM, Akkerhuis KM, Battes LC, van Vark LC, Hillege HL, Paulus WJ, Boersma E, Kardys I.

Eur J Heart Fail. 2013 Dec;15(12):1350-62. doi: 10.1093/eurjhf/hft106. Epub 2013 Jul 11. Review.

PMID:
23845797
6.

Novel biomarkers in heart failure with preserved ejection fraction.

Shah KS, Maisel AS.

Heart Fail Clin. 2014 Jul;10(3):471-9. doi: 10.1016/j.hfc.2014.04.005. Review.

PMID:
24975910
7.

Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.

Palazzuoli A, Masson S, Ronco C, Maisel A.

Heart Fail Rev. 2014 Mar;19(2):267-84. doi: 10.1007/s10741-013-9391-x. Review.

PMID:
23563622
8.

Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.

de Denus S, Lavoie J, Ducharme A, O'Meara E, Racine N, Sirois MG, Neagoe PE, Zhu L, Rouleau JL, White M.

Can J Cardiol. 2012 Jan-Feb;28(1):62-8. doi: 10.1016/j.cjca.2011.09.007. Epub 2011 Nov 21.

PMID:
22104539
9.

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

Martos R, Baugh J, Ledwidge M, O'Loughlin C, Murphy NF, Conlon C, Patle A, Donnelly SC, McDonald K.

Eur J Heart Fail. 2009 Feb;11(2):191-7. doi: 10.1093/eurjhf/hfn036.

10.

The use of biomarkers in the patient with heart failure.

Chowdhury P, Kehl D, Choudhary R, Maisel A.

Curr Cardiol Rep. 2013 Jun;15(6):372. doi: 10.1007/s11886-013-0372-4. Review.

PMID:
23644993
11.

Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Zile MR, Baicu CF.

J Cardiovasc Transl Res. 2013 Aug;6(4):501-15. doi: 10.1007/s12265-013-9472-1. Epub 2013 May 29. Review.

PMID:
23716130
12.

Diagnosing heart failure with preserved ejection fraction.

Becher PM, Lindner D, Fluschnik N, Blankenberg S, Westermann D.

Expert Opin Med Diagn. 2013 Sep;7(5):463-74. doi: 10.1517/17530059.2013.825246. Epub 2013 Aug 9. Review.

PMID:
23930995
13.

[Heart failure with preserved ejection fraction: Diastolic heart failure].

Rutten FH, Cramer MJ, Paulus WJ.

Ned Tijdschr Geneeskd. 2012;156(45):A5315. Review. Dutch.

PMID:
23134752
14.

Hypertension as an underlying factor in heart failure with preserved ejection fraction.

Volpe M, McKelvie R, Drexler H.

J Clin Hypertens (Greenwich). 2010 Apr;12(4):277-83. doi: 10.1111/j.1751-7176.2009.00253.x. Review.

PMID:
20433548
15.
16.

Soluble ST2 and galectin-3 in heart failure.

Shah RV, Januzzi JL Jr.

Clin Lab Med. 2014 Mar;34(1):87-97, vi-vii. doi: 10.1016/j.cll.2013.11.009. Epub 2014 Jan 14. Review.

PMID:
24507789
17.

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL.

Eur Heart J. 2007 Oct;28(20):2539-50. Epub 2007 Apr 11.

18.

Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

Gopal DM, Kommineni M, Ayalon N, Koelbl C, Ayalon R, Biolo A, Dember LM, Downing J, Siwik DA, Liang CS, Colucci WS.

J Am Heart Assoc. 2012 Oct;1(5):e000760. doi: 10.1161/JAHA.112.000760. Epub 2012 Oct 25. Erratum in: J Am Heart Assoc. 2013 Jun;2(3):e000194.

19.

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators.

Circ Heart Fail. 2012 May 1;5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242. Epub 2012 Mar 22.

20.

Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers.

Biolo A, Fisch M, Balog J, Chao T, Schulze PC, Ooi H, Siwik D, Colucci WS.

Circ Heart Fail. 2010 Jan;3(1):44-50. doi: 10.1161/CIRCHEARTFAILURE.108.844324. Epub 2009 Oct 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk